chrX-153418700-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001386943.1(ZFP92):c.-66G>C variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000343 in 1,165,877 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 6 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001386943.1 5_prime_UTR_premature_start_codon_gain
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000628 AC: 7AN: 111511Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33715
GnomAD3 exomes AF: 0.000259 AC: 30AN: 115992Hom.: 0 AF XY: 0.000121 AC XY: 5AN XY: 41438
GnomAD4 exome AF: 0.0000313 AC: 33AN: 1054315Hom.: 0 Cov.: 31 AF XY: 0.0000174 AC XY: 6AN XY: 344905
GnomAD4 genome AF: 0.0000627 AC: 7AN: 111562Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 33776
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.61G>C (p.V21L) alteration is located in exon 2 (coding exon 2) of the ZFP92 gene. This alteration results from a G to C substitution at nucleotide position 61, causing the valine (V) at amino acid position 21 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at